 |
Code of Federal Regulations (Last Updated: October 10, 2024) |
 |
Title 42 - Public Health |
|
|
Chapter IV - Centers for Medicare & Medicaid Services, Department of Health and Human Services |
|
|
SubChapter C - Medical Assistance Programs |
|
|
Part 447 - Payments for Services |
|
|
Subpart I - Payment for Drugs |
| § 447.500 - Basis and purpose. |
| § 447.502 - Definitions. |
| § 447.504 - Determination of average manufacturer price. |
| § 447.505 - Determination of best price. |
| § 447.506 - Authorized generic drugs. |
| § 447.507 - Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs). |
| § 447.508 - Exclusion from best price of certain sales at a nominal price. |
| § 447.509 - Medicaid drug rebates (MDR). |
| § 447.510 - Requirements for manufacturers. |
| § 447.511 - Requirements for States. |
| § 447.512 - Drugs: Aggregate upper limits of payment. |
| § 447.514 - Upper limits for multiple source drugs. |
| § 447.516 - Upper limits for drugs furnished as part of services. |
| § 447.518 - State plan requirements, findings, and assurances. |
| § 447.520 - Federal Financial Participation (FFP): Conditions relating to physician-administered drugs. |
| § 447.522 - Optional coverage of investigational drugs and other drugs not subject to rebate. |
| §§ 447.500--447.532 - [Reserved] |
| § 447.534 - Manufacturer reporting requirements. |
| §§ 447.536--447.550 - [Reserved] |